Setting 
My Cart

Ordered before 17:30, shipped today - Support: (012) 800 456 789

Track Your Order

Toggle Nav
mobile icon
Close
  • Menu
  • Setting
  • Home
  • Search results for: 'research area dna damage dna hdac'

Search results for: 'research area dna damage dna hdac'

Items 1-10 of 75

Page
per page
  1. Gemcitabine HCl
    A1402 Gemcitabine HCl
    Summary: Inhibits DNA synthesis,deoxycytidine analog
      ≥10.1 mg/mL
  2. Cytarabine
    A8405 Cytarabine
     1 Citation
    Summary: cytotoxic agent, blocks DNA synthesis
      insoluble in EtOH; ≥28.6 mg/mL
  3. Carboplatin
    A2171 Carboplatin
    Summary: Antitumor agent that forms platinum-DNA adducts.
      insoluble in ETOH; ≥9.28 mg/mL
  4. Fludarabine Phosphate (Fludara)
    A8317 Fludarabine Phosphate (Fludara)
     2 Citation
    Target: STAT
    Summary: Inhibits STAT1 activation and DNA synthesis
      insoluble in EtOH; ≥17.6 mg/mL
  5. NU 7026
    A8649 NU 7026
    Target: PI3K|DNA-PK|ATM
    Summary: DNPK inhibitor,ATP-competitive and potent
      insoluble in EtOH; insoluble in DMSO; insoluble in H2O
  6. Oxaliplatin
    A8648 Oxaliplatin
     3 Citation
    Summary: Antitumor agent
      insoluble in EtOH; ≥37.25 mg/mL
  7. Fludarabine
    A5424 Fludarabine
    Summary: DNA synthsis inhibitor
      insoluble in H2O; insoluble in EtOH; ≥9.25 mg/mL
  8. Bleomycin Sulfate
    A8331 Bleomycin Sulfate
     1 Citation
    Summary: Chemotherapy agent, induces DNA strand break
      ≥125 mg/mL
  9. Capecitabine
    A8647 Capecitabine
    Summary: DNA, RNA and protein synthesis inhibitor
      ≥10.97 mg/mL
  10. Epirubicin HCl
    A2451 Epirubicin HCl
    Target: Topoisomerases
    Summary: Antibiotic antitumor agent
      ≥29.00 mg/mL

Items 1-10 of 75

Page
per page
Shop By
Now Shopping by
  1. Reported Experiments Cell Experiments Remove This Item
Clear All
Shopping Options
Category
  1. Signaling Pathways 70item
  2. Natural Products 2item
  3. Protein 2item
  4. Peptides & Proteins 3item
  5. Lab Reagents 1 item
Specificity
  1. Selective 41item
Reversibility
  1. Reversible 3item
Target
  1. Histone Deacetylases (HDACs) 22item
  2. Akt 1 item
  3. PI3K 5item
  4. mTOR 4item
  5. AP-1 1 item
  6. Thymidylate Synthase 1 item
  7. STAT 3item
  8. Estrogen and Related Receptors 1 item
  9. EGFR 2item
  10. Reverse Transcriptases 1 item
  11. JAK 1 item
  12. DNA-PK 5item
  13. Topoisomerases 7item
  14. ErbB 1 item
  15. DNA Methyltransferases 1 item
  16. ATM/ATR 3item
  17. HIV Integrases 1 item
  18. BLM 1 item
  19. HSV 1 item
  20. Synthases/Synthetases 2item
  21. MAGL 1 item
  22. Histamine H1 Receptors 1 item
  23. RNA Polymerases 2item
  24. CMV 1 item
  25. O6-methylguanine-DNA-methyl-transferase (MGMT) 1 item
  26. Cytidine deaminases 1 item
  27. p53 1 item
  28. HDAC 2item
  29. PPAR 1 item
  30. PTK 1 item
  31. prolactin secretion 1 item
  32. gonadotropin release 1 item
  33. DNA Ligases 1 item
  34. TRPC channel 1 item
  35. ATM 1 item
  36. Sirtuin 1 item
Related Disease
  1. Acute Myelogenous Leukemia 3item
  2. Acute Renal Failure 1 item
  3. Bladder Cancer 2item
  4. Bladder Carcinoma 1 item
  5. Bladder Diseases 1 item
  6. Breast Cancer 11item
  7. Cancer 42item
  8. Cervical Cancer 1 item
  9. Chronic Lymphocytic Leukemia 1 item
  10. Colon Cancer 4item
  11. Colorectal Cancer 4item
  12. Dyskinesia 1 item
  13. Friedreich's Ataxia 1 item
  14. Glioblastoma 1 item
  15. Glioma 1 item
  16. Hepatocellular Carcinoma 1 item
  17. HIV 2item
  18. HIV Infections 2item
  19. Inflammatory Diseases 1 item
  20. Leukemia 3item
  21. Lung Cancer 2item
  22. Lymphoma 3item
  23. Melanoma 4item
  24. Multiple Myeloma 2item
  25. Myeloma 1 item
  26. Neuroblastoma 1 item
  27. Neuronal Protection 1 item
  28. Non-small Cell Lung Cancer 1 item
  29. Ovarian Cancer 4item
  30. Pancreatic Cancer 2item
  31. Prostate Cancer 7item
  32. Renal Cancer 1 item
  33. Sarcoma 1 item
  34. Squamous Cell Carcinoma 1 item